Statement for the open session of the meeting of the 25th WHO Expert Committee on the Selection and Use of Essential Medicines - May 5 to 9

This statement has been drafted by the NCD Alliance and supported by the Global Initiative for Chronic Obstructive Lung Disease, the Forum of International Respiratory Societies, The International Union Against Tuberculosis and Lung Disease, International Diabetes Federation, MedAccess, East Africa Diabetes Study Group, European Federation of Neurological Associations, One Neurology Partnership, Union for International Cancer Control, Medicines Patent Pool, Access to Medicines Foundation, University of Geneva, NCD Policy Lab.